Use of c-peptide as a measure of cephalic phase insulin release in humans
- PMID: 35961609
- PMCID: PMC9993810
- DOI: 10.1016/j.physbeh.2022.113940
Use of c-peptide as a measure of cephalic phase insulin release in humans
Abstract
Cephalic phase insulin release (CPIR) is a rapid pulse of insulin secreted within minutes of food-related sensory stimulation. Understanding the mechanisms underlying CPIR in humans has been hindered by its small observed effect size and high variability within and between studies. One contributing factor to these limitations may be the use of peripherally measured insulin as an indicator of secreted insulin, since a substantial portion of insulin is metabolized by the liver before delivery to peripheral circulation. Here, we investigated the use of c-peptide, which is co-secreted in equimolar amounts to insulin from pancreatic beta cells, as a proxy for insulin secretion during the cephalic phase period. Changes in insulin and c-peptide were monitored in 18 adults over two repeated sessions following oral stimulation with a sucrose-containing gelatin stimulus. We found that, on average, insulin and c-peptide release followed a similar time course over the cephalic phase period, but that c-peptide showed a greater effect size. Importantly, when insulin and c-peptide concentrations were compared across sessions, we found that changes in c-peptide were significantly correlated at the 2 min (r = 0.50, p = 0.03) and 4 min (r = 0.65, p = 0.003) time points, as well as when participants' highest c-peptide concentrations were considered (r = 0.64, p = 0.004). In contrast, no significant correlations were observed for changes in insulin measured from the sessions (r = -0.06-0.35, p > 0.05). Herein, we detail the individual variability of insulin and c-peptide concentrations measured during the cephalic phase period, and identify c-peptide as a valuable metric for insulin secretion alongside insulin concentrations when investigating CPIR.
Keywords: C-peptide; Cephalic phase; Individual differences; Oral stimulation; Preabsorptive insulin release.
Copyright © 2022. Published by Elsevier Inc.
Conflict of interest statement
Declaration of Competing Interest
The authors declare no competing financial interests.
Figures





Similar articles
-
Oral glucose sensing in cephalic phase insulin release.Appetite. 2023 Dec 1;191:107070. doi: 10.1016/j.appet.2023.107070. Epub 2023 Oct 1. Appetite. 2023. PMID: 37788735 Clinical Trial.
-
Oral stimulation with maltodextrin: Effect on cephalic phase insulin release.Appetite. 2023 Apr 1;183:106464. doi: 10.1016/j.appet.2023.106464. Epub 2023 Jan 20. Appetite. 2023. PMID: 36682624
-
A single night of partial sleep loss impairs fasting insulin sensitivity but does not affect cephalic phase insulin release in young men.J Sleep Res. 2016 Feb;25(1):5-10. doi: 10.1111/jsr.12340. J Sleep Res. 2016. PMID: 26361380 Clinical Trial.
-
Cephalic phase insulin release: A review of its mechanistic basis and variability in humans.Physiol Behav. 2021 Oct 1;239:113514. doi: 10.1016/j.physbeh.2021.113514. Epub 2021 Jul 9. Physiol Behav. 2021. PMID: 34252401 Free PMC article. Review.
-
Evidence for cephalic phase insulin release in humans: A systematic review and meta-analysis.Appetite. 2020 Dec 1;155:104792. doi: 10.1016/j.appet.2020.104792. Epub 2020 Jul 21. Appetite. 2020. PMID: 32707265
Cited by
-
[Value of C-peptide-based insulin resistance index for evaluating correlation between insulin resistance and serum uric acid level in individuals undergoing health examination].Nan Fang Yi Ke Da Xue Xue Bao. 2023 Sep 20;43(9):1509-1514. doi: 10.12122/j.issn.1673-4254.2023.09.08. Nan Fang Yi Ke Da Xue Xue Bao. 2023. PMID: 37814865 Free PMC article. Chinese.
-
The elusive cephalic phase insulin response: triggers, mechanisms, and functions.Physiol Rev. 2023 Apr 1;103(2):1423-1485. doi: 10.1152/physrev.00025.2022. Epub 2022 Nov 24. Physiol Rev. 2023. PMID: 36422994 Free PMC article. Review.
References
-
- Ahrén B, Holst JJ, The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia, Diabetes 50 (2001) 1030. - PubMed
-
- Calles-Escandon J, Robbins DC, Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose, Diabetes 36 (1987) 1167. - PubMed
-
- Lorentzen M, Madsbad S, Kehlet H, Tronier B, Effect of sham-feeding on glucose tolerance and insulin secretion, Acta Endocrinol. 115 (1987) 84–86. - PubMed
-
- Teff K, Engelman K, Oral sensory stimulation improves glucose tolerance in humans: effects on insulin, C-peptide, and glucagon, Am. J. Physiol. Regul. Integr. Comp. Physiol. 270 (1996) R1371–R1379. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical